For the first time ... a possible treatment for the loss of nerve appetite

In a step that is the first of its kind to investigate the psychological effects of drugs on one of the most difficult psychological disorders, ‘nerve loss’, researchers from the University of California in San Diego offered an extensive analysis of a clinical experience of which the results in the journal Nature Medicine were published. The study was about the effect of ‘cello-bien’ treatment- an narcotic compound extracted from mushrooms- on people with nervous loss, which is one of the highest mental illnesses of death rates, and is usually against traditional treatments. The study provides unique visions on how “cellosipine” therapy affects patients with nerve loss, and the opinions of patients themselves reflect by semi -organized interviews, extensive assessments, which reveal promising results and important challenges that can affect the treatment approach in the future. Nervous loss and nervous losses are one of the most dangerous mental disorders, and is characterized by high deaths, and this mainly affects women, and people with this deviation have a serious anxiety about weight and body shape, and they can refrain from eating to the extent that they seriously affect their health, and despite the many efforts to treat it by medicine and psychotherapy, Innovative solutions. And ‘CellosaBin’ is one of the controversial compounds that has shown a possible ability over the past few years to treat different psychological disorders such as depression, anxiety disorders, and its work mechanism depends on the influence of serotonin receptors in the brain, leading to deep psychological experiences and transformations in thinking and perception. Unlike traditional treatments, ‘CellosaBin’ opens new doors to understand the deep aspects of mental illness, making it a promising option to treat cases that are difficult to achieve concrete results. A group of patients who received a single dose of ‘cello -bine’ participated in the study with a concentration of 25 milligrams, accompanied by special psychological support before, during and after the session, and the results were surprising and promising. 90% of participants said their experience with ‘CellosaBin’ was one of the five most important life experiences they lived, and 40% of participants showed a remarkable decrease in the symptoms of eating disorders, especially the concerns associated with the form of the body and weight, while 70% of participants reported that a improvement in their own changes. 70% of participants reported an improvement in the quality of their lives, and they felt internal changes in their view of themselves, even if these changes were not significant in their external appearance or weight. Despite the positive results, the study indicates that this treatment does not treat all aspects of nervous anorexia, and changes in the psychological view of the participants did not lead to weight significantly, emphasizing the need for psychotherapy integration with diet. Genetic factors and the experiment showed that some patients respond better than others, and raised questions about the role of genetic factors and the contrast of serotonin receptors to affect the effectiveness of treatment. The study recommends the need to do more research, especially those that include the use of brain imaging techniques and the analysis of genetic factors, to better understand the response mechanisms for treatment. The researchers say that the treatment with ‘Cellosa Bien’ emphasizes a traditional treatment option as it can contribute to improving positive psychological changes in patients. If the effectiveness of the treatment is proven by extensive additional experiments, psychotherapy with ‘cellosipine’ can become part of the future treatment protocols for nerve loss. This study indicates that ‘cellosipine’ can provide a new window to treat treatment for treatment, increasing the possibilities of deep psychological change in patients with eating disorders.